(SNBR) Sleep Number - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US83125X1037
Smart Beds, Adjustable Bases, Pillows, Sheets, Bedding
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 100% |
| Value at Risk 5%th | 136% |
| Relative Tail Risk | -17.51% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.36 |
| Alpha | -80.96 |
| CAGR/Max DD | -0.36 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.780 |
| Beta | 1.916 |
| Beta Downside | 2.166 |
| Drawdowns 3y | |
|---|---|
| Max DD | 91.05% |
| Mean DD | 60.28% |
| Median DD | 65.37% |
Description: SNBR Sleep Number October 29, 2025
Sleep Number Corp (NASDAQ: SNBR) designs, manufactures, markets and services a portfolio of sleep solutions-including smart beds, adjustable bases, pillows and bedding-through a direct-to-consumer model that spans retail stores, e-commerce, phone and chat channels. The firm, originally incorporated as Select Comfort in 1987 and renamed in 2017, is headquartered in Minneapolis, Minnesota, and operates within the Homefurnishing Retail sub-industry.
Key recent metrics (FY 2023) show revenue of roughly $1.6 billion, a gross margin near 38 %, and a 12 % year-over-year increase in online sales share, now accounting for about 30 % of total revenue. The business is sensitive to macro-level consumer discretionary spending and housing market dynamics; higher interest rates tend to suppress new-home purchases and, by extension, furniture demand, while a continued shift toward “smart home” integration supports premium pricing for connected sleep products. The broader home-furnishings sector is also benefitting from a modest rebound in in-store traffic after pandemic-era lockdowns, which helps drive same-store sales growth.
For a deeper quantitative dive-including valuation multiples, peer comparisons, and scenario analysis-explore the detailed analyst toolkit on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (-78.1m TTM) > 0 and > 6% of Revenue (6% = 86.5m TTM) |
| FCFTA -0.07 (>2.0%) and ΔFCFTA -4.79pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -50.59% (prev -41.72%; Δ -8.88pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.04 (>3.0%) and CFO -28.5m > Net Income -78.1m (YES >=105%, WARN >=100%) |
| Net Debt (939.4m) to EBITDA (22.8m) ratio: 41.13 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.19 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (23.0m) change vs 12m ago 1.66% (target <= -2.0% for YES) |
| Gross Margin 60.05% (prev 58.80%; Δ 1.25pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 178.5% (prev 200.7%; Δ -22.12pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.76 (EBITDA TTM 22.8m / Interest Expense TTM 47.2m) >= 6 (WARN >= 3) |
Altman Z'' -9.54
| (A) -0.97 = (Total Current Assets 169.8m - Total Current Liabilities 898.8m) / Total Assets 749.4m |
| (B) -0.74 = Retained Earnings (Balance) -552.6m / Total Assets 749.4m |
| (C) -0.04 = EBIT TTM -35.8m / Avg Total Assets 807.0m |
| (D) -0.43 = Book Value of Equity -552.4m / Total Liabilities 1.27b |
| Total Rating: -9.54 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 16.64
| 1. Piotroski 2.0pt |
| 2. FCF Yield -4.58% |
| 3. FCF Margin -3.47% |
| 4. Debt/Equity -1.80 |
| 5. Debt/Ebitda 41.13 |
| 6. ROIC - WACC (= -34.53)% |
| 7. RoE 16.35% |
| 8. Rev. Trend -91.30% |
| 9. EPS Trend -75.60% |
What is the price of SNBR shares?
As of December 14, 2025, the stock is trading at USD 8.46 with a total of 769,961 shares traded.
Over the past week, the price has changed by +27.03%, over one month by +100.95%, over three months by -9.81% and over the past year by -58.20%.
Over the past week, the price has changed by +27.03%, over one month by +100.95%, over three months by -9.81% and over the past year by -58.20%.
Is SNBR a buy, sell or hold?
Sleep Number has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold SNBR.
- Strong Buy: 0
- Buy: 0
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SNBR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 5.5 | -35% |
| Analysts Target Price | 5.5 | -35% |
| ValueRay Target Price | 5.8 | -31.6% |
SNBR Fundamental Data Overview December 03, 2025
Market Cap USD = 151.8m (151.8m USD * 1.0 USD.USD)
P/E Forward = 714.2857
P/S = 0.1053
Beta = 1.914
Revenue TTM = 1.44b USD
EBIT TTM = -35.8m USD
EBITDA TTM = 22.8m USD
Long Term Debt = 546.8m USD (from longTermDebt, last fiscal year)
Short Term Debt = 661.5m USD (from shortTermDebt, last quarter)
Debt = 940.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 939.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.09b USD (151.8m + Debt 940.7m - CCE 1.26m)
Interest Coverage Ratio = -0.76 (Ebit TTM -35.8m / Interest Expense TTM 47.2m)
FCF Yield = -4.58% (FCF TTM -50.0m / Enterprise Value 1.09b)
FCF Margin = -3.47% (FCF TTM -50.0m / Revenue TTM 1.44b)
Net Margin = -5.42% (Net Income TTM -78.1m / Revenue TTM 1.44b)
Gross Margin = 60.05% ((Revenue TTM 1.44b - Cost of Revenue TTM 575.6m) / Revenue TTM)
Gross Margin QoQ = 59.90% (prev 59.08%)
Tobins Q-Ratio = 1.46 (Enterprise Value 1.09b / Total Assets 749.4m)
Interest Expense / Debt = 1.35% (Interest Expense 12.7m / Debt 940.7m)
Taxrate = 24.93% (-13.2m / -53.0m)
NOPAT = -26.8m (EBIT -35.8m * (1 - 24.93%)) [loss with tax shield]
Current Ratio = 0.19 (Total Current Assets 169.8m / Total Current Liabilities 898.8m)
Debt / Equity = -1.80 (negative equity) (Debt 940.7m / totalStockholderEquity, last quarter -521.3m)
Debt / EBITDA = 41.13 (Net Debt 939.4m / EBITDA 22.8m)
Debt / FCF = -18.80 (negative FCF - burning cash) (Net Debt 939.4m / FCF TTM -50.0m)
Total Stockholder Equity = -477.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -10.42% (Net Income -78.1m / Total Assets 749.4m)
RoE = 16.35% (negative equity) (Net Income TTM -78.1m / Total Stockholder Equity -477.6m)
RoCE = -51.66% (EBIT -35.8m / Capital Employed (Equity -477.6m + L.T.Debt 546.8m))
RoIC = -31.84% (negative operating profit) (NOPAT -26.8m / Invested Capital 84.3m)
WACC = 2.69% (E(151.8m)/V(1.09b) * Re(13.07%) + D(940.7m)/V(1.09b) * Rd(1.35%) * (1-Tc(0.25)))
Discount Rate = 13.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.06%
Fair Price DCF = unknown (Cash Flow -50.0m)
EPS Correlation: -75.60 | EPS CAGR: -68.73% | SUE: -4.0 | # QB: 0
Revenue Correlation: -91.30 | Revenue CAGR: -9.18% | SUE: -1.22 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.20 | Chg30d=-0.325 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.97 | Chg30d=-1.180 | Revisions Net=+0 | Growth EPS=+74.3% | Growth Revenue=-1.3%
P/E Forward = 714.2857
P/S = 0.1053
Beta = 1.914
Revenue TTM = 1.44b USD
EBIT TTM = -35.8m USD
EBITDA TTM = 22.8m USD
Long Term Debt = 546.8m USD (from longTermDebt, last fiscal year)
Short Term Debt = 661.5m USD (from shortTermDebt, last quarter)
Debt = 940.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 939.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.09b USD (151.8m + Debt 940.7m - CCE 1.26m)
Interest Coverage Ratio = -0.76 (Ebit TTM -35.8m / Interest Expense TTM 47.2m)
FCF Yield = -4.58% (FCF TTM -50.0m / Enterprise Value 1.09b)
FCF Margin = -3.47% (FCF TTM -50.0m / Revenue TTM 1.44b)
Net Margin = -5.42% (Net Income TTM -78.1m / Revenue TTM 1.44b)
Gross Margin = 60.05% ((Revenue TTM 1.44b - Cost of Revenue TTM 575.6m) / Revenue TTM)
Gross Margin QoQ = 59.90% (prev 59.08%)
Tobins Q-Ratio = 1.46 (Enterprise Value 1.09b / Total Assets 749.4m)
Interest Expense / Debt = 1.35% (Interest Expense 12.7m / Debt 940.7m)
Taxrate = 24.93% (-13.2m / -53.0m)
NOPAT = -26.8m (EBIT -35.8m * (1 - 24.93%)) [loss with tax shield]
Current Ratio = 0.19 (Total Current Assets 169.8m / Total Current Liabilities 898.8m)
Debt / Equity = -1.80 (negative equity) (Debt 940.7m / totalStockholderEquity, last quarter -521.3m)
Debt / EBITDA = 41.13 (Net Debt 939.4m / EBITDA 22.8m)
Debt / FCF = -18.80 (negative FCF - burning cash) (Net Debt 939.4m / FCF TTM -50.0m)
Total Stockholder Equity = -477.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -10.42% (Net Income -78.1m / Total Assets 749.4m)
RoE = 16.35% (negative equity) (Net Income TTM -78.1m / Total Stockholder Equity -477.6m)
RoCE = -51.66% (EBIT -35.8m / Capital Employed (Equity -477.6m + L.T.Debt 546.8m))
RoIC = -31.84% (negative operating profit) (NOPAT -26.8m / Invested Capital 84.3m)
WACC = 2.69% (E(151.8m)/V(1.09b) * Re(13.07%) + D(940.7m)/V(1.09b) * Rd(1.35%) * (1-Tc(0.25)))
Discount Rate = 13.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.06%
Fair Price DCF = unknown (Cash Flow -50.0m)
EPS Correlation: -75.60 | EPS CAGR: -68.73% | SUE: -4.0 | # QB: 0
Revenue Correlation: -91.30 | Revenue CAGR: -9.18% | SUE: -1.22 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.20 | Chg30d=-0.325 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.97 | Chg30d=-1.180 | Revisions Net=+0 | Growth EPS=+74.3% | Growth Revenue=-1.3%
Additional Sources for SNBR Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle